In-silico screening is changing drug discovery timelines

Traditional drug discovery: 10-15 years, B+ per approved drug. Most of that time is in early-stage compound identification and optimization.\n\nIn-silico screening can compress the early stages dramatically. What used to take 6 months of wet-lab screening can be done computationally in days:\n\n- Docking simulations filter a 10M compound library to 10K candidates\n- ADMET prediction eliminates toxicity and bioavailability failures before synthesis\n- Molecular dynamics validates binding stability on top candidates\n\nThe agent layer is critical for orchestrating these pipelines. A computational chemist doesn't run one simulation — they run thousands in parallel, track results, update hypotheses, and prioritize the next round.\n\nWe're not replacing medicinal chemists. We're giving them 100x more experiments per day.